L. B. S. Gelinck

The effect of anti-tumour necrosis factor α treatment on the antibody response to influenza vaccination

L. B. S. Gelinck, A. E. van der Bijl, W.E.P. Beyer et al. · Annals of the Rheumatic Diseases · 2007 · 174 citations

An Outbreak of Pneumocystis jiroveci Pneumonia with 1 Predominant Genotype among Renal Transplant Recipients: Interhuman Transmission or a Common Environmental Source?

Mark de Boer, L.E.S. Bruijnesteijn van Coppenraet, André Gaasbeek et al. · Clinical Infectious Diseases · 2007 · 151 citations

Middle East respiratory syndrome coronavirus (MERS-CoV) infections in two returning travellers in the Netherlands, May 2014

Marleen Kraaij – Dirkzwager, Aura Timen, Kees Dirksen et al. · Eurosurveillance · 2014 · 76 citations · Full text

Community-acquired Infection, Virus Epidemiology, Emerging Infectious Diseases +15

HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study

Colette Smit, Anders Boyd, Bart Rijnders et al. · The Lancet HIV · 2020 · 72 citations · Full text

Retrospective Cohort Study, Treatment And Prevention, Human Retrovirus +9

β-d-Glucan and S-adenosylmethionine serum levels for the diagnosis of Pneumocystis pneumonia in HIV-negative Patients: A prospective study

Mark de Boer, L. B. S. Gelinck, Bertrand D. van Zelst et al. · Journal of Infection · 2010 · 71 citations

Pneumocystis Pneumonia, S-adenosylmethionine Serum Levels, Hiv +2